A smartphone app designed by Pear Therapeutics has received FDA clearance for treating patients suffering from opioid abuse. This is the first prescription digital therapeutic to treat opioid addiction to be cleared by the FDA.
The app will be used in conjunction with standard outpatient treatment to provide interactive therapy lessons that challenge destructive behaviors, help develop coping strategies and reinforce the importance of taking medication.
Commercialization of the reSET-O app will be led by Novartis’ Sandoz unit and is expected to launch by the end of the year.
Click here to read the entire article.